These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 18975338

  • 1. Resolution of gouty tophi after twelve weeks of pegloticase treatment.
    Baraf HS, Matsumoto AK, Maroli AN, Waltrip RW.
    Arthritis Rheum; 2008 Nov; 58(11):3632-4. PubMed ID: 18975338
    [No Abstract] [Full Text] [Related]

  • 2. Pegloticase (krystexxa) for treatment of refractory gout.
    Med Lett Drugs Ther; 2011 Feb 07; 53(1357):9-10. PubMed ID: 21304442
    [No Abstract] [Full Text] [Related]

  • 3. Tophus resolution in patients with chronic refractory gout who have persistent urate-lowering responses to pegloticase.
    Mandell BF, Yeo AE, Lipsky PE.
    Arthritis Res Ther; 2018 Dec 29; 20(1):286. PubMed ID: 30594229
    [Abstract] [Full Text] [Related]

  • 4. Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.
    Sundy JS, Becker MA, Baraf HS, Barkhuizen A, Moreland LW, Huang W, Waltrip RW, Maroli AN, Horowitz Z, Pegloticase Phase 2 Study Investigators.
    Arthritis Rheum; 2008 Sep 29; 58(9):2882-91. PubMed ID: 18759308
    [Abstract] [Full Text] [Related]

  • 5. Population pharmacokinetic and pharmacodynamic analysis of pegloticase in subjects with hyperuricemia and treatment-failure gout.
    Yue CS, Huang W, Alton M, Maroli AN, Waltrip RW, Wright D, Marco MD.
    J Clin Pharmacol; 2008 Jun 29; 48(6):708-18. PubMed ID: 18420531
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials.
    Strand V, Khanna D, Singh JA, Forsythe A, Edwards NL.
    J Rheumatol; 2012 Jul 29; 39(7):1450-7. PubMed ID: 22660805
    [Abstract] [Full Text] [Related]

  • 10. Reversal of chronic refractory tophaceous gout with erosions with pegloticase.
    Yeter KC, Ortiz EC, Arkfeld DG.
    Int J Rheum Dis; 2013 Jun 29; 16(3):369-70. PubMed ID: 23981765
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.
    Baraf HS, Becker MA, Gutierrez-Urena SR, Treadwell EL, Vazquez-Mellado J, Rehrig CD, Ottery FD, Sundy JS, Yood RA.
    Arthritis Res Ther; 2013 Sep 26; 15(5):R137. PubMed ID: 24286509
    [Abstract] [Full Text] [Related]

  • 13. Pegloticase and lowering blood pressure in refractory gout; is it uric acid or hydrogen peroxide?
    Fini MA, Stenmark KR.
    Eur J Intern Med; 2019 Nov 26; 69():e11-e12. PubMed ID: 31471165
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation and treatment of gout as a chronic disease.
    Perez-Ruiz F, Herrero-Beites AM.
    Adv Ther; 2012 Nov 26; 29(11):935-46. PubMed ID: 23104464
    [Abstract] [Full Text] [Related]

  • 15. Exploratory study of radiographic change in patients with tophaceous gout treated with intensive urate-lowering therapy.
    Dalbeth N, Doyle AJ, McQueen FM, Sundy J, Baraf HS.
    Arthritis Care Res (Hoboken); 2014 Jan 26; 66(1):82-5. PubMed ID: 23836458
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.